secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2025-03-26T23:59:59+00:00
Accession:  0001641172-25-000788
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology reduces ATM offering capacity from $30M to $11.2M
--------------------------------------------------------------------

- Maximum aggregate offering price reduced from $30M to $11.2M under ATM with H.C. Wainwright.
- Prior sales: $6.29M in last 12 months, $11.63M total under the agreement.
- Prospectus supplement dated March 26, 2025 filed for the $11.2M offering.
- No reason given for reduction; company continues at-the-market program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225000788/0001641172-25-000788-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225000788/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-000788

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer